Showing 1501-1510 of 5959 results for "".
DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleVitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.Topical Psoriasis Therapies: An Update
https://practicaldermatology.com/topics/psoriasis/topical-psoriasis-therapies-an-update/23009/The latest research offers insights on the benefits and utility of topical treatment.Statins and Skin Cancer: The Latest Data
https://practicaldermatology.com/topics/skin-cancer-photoprotection/statins-and-skin-cancer-the-latest-data/20426/A look at another commonly used drug and its potential association with skin cancer risks.Physician Spotlight: Gary Goldenberg, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-gary-goldenberg-md/20424/It's all hands on deck when building out a new dermatology practice.The First 5 Minutes with a Patient
https://practicaldermatology.com/series/pa-perspectives/first-5-minutes-patient/27105/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient.Treatment of Psychodermatological Conditions Using N-acetylcysteine
https://practicaldermatology.com/columns/physician-spotlight/treatment-of-psychodermatological-conditions-using-n-acetylcysteine/23998/The low risk, high reward of NAC suggests its great promise in a supplementary role for treatment of trichotillomania and excoriation disorder.Treating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.Reimagining Melanoma Diagnosis with Genomic Analysis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/reimagining-melanoma-diagnosis-with-genomic-analysis/23484/A non-invasive test allows for genetic assessment of suspicious lesions.DermWire TV: Kysse Approved, Sunscreen Use Trends, AbbVie/Allergan Deal
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwire-tv-kysse-approved-sunscreen-use-trends-abbvieallergan-deal/19812/Galderma's Restylane Kysse is now FDA approved for lip augmentation and the correction of wrinkles around the upper lips in adults. Americans understand that sunscreen use is important to protect the skin, but they still don’t use SPF regularly, AAD data reveal. AbbVie has completed its acquisition